FDA 483 - Virbac Corporation - November 25, 2019

An FDA inspection of Virbac Corporation, an animal drug manufacturer in Bridgeton, MO, revealed significant deficiencies in laboratory controls and investigation procedures. The firm lacked scientifically sound test methods for product impurities, failed to properly investigate out-of-specification results and product contamination, and exhibited poor data integrity practices. These issues indicate a systemic breakdown in quality control for their animal drug products.